Cite
HARVARD Citation
Shaul, A. et al. (2017). Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes—Good or excellent?. Diabetes/metabolism research and reviews. 33 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shaul, A. et al. (2017). Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes—Good or excellent?. Diabetes/metabolism research and reviews. 33 (5), p. n/a. [Online].